FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
about
The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid ArthritisSTAT6 and STAT1 Pathway Activation in Circulating Lymphocytes and Monocytes as Predictor of Treatment Response in Rheumatoid ArthritisThe fate and lifespan of human monocyte subsets in steady state and systemic inflammationBlood monocyte subsets and selected cardiovascular risk markers in rheumatoid arthritis of short duration in relation to disease activityPotent anti-inflammatory effects of the narrow spectrum kinase inhibitor RV1088 on rheumatoid arthritis synovial membrane cells.The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myelomaA common glycan structure on immunoglobulin G for enhancement of effector functionsOverexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists.Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective studySources of heterogeneity in human monocyte subsets.Perturbations of Monocyte Subsets and Their Association with T Helper Cell Differentiation in Acute and Chronic HIV-1-Infected Patients.Transcriptomic network support distinct roles of classical and non-classical monocytes in human.Targeting monocyte and macrophage subpopulations for immunotherapy: a patent review (2009 - 2013).Clinical significance of monocyte heterogeneity.Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers.Toward a refined definition of monocyte subsets.Functional Defects in Type 3 Innate Lymphoid Cells and Classical Monocytes in a Patient with Hyper-IgE Syndrome.Affimer proteins inhibit immune complex binding to FcγRIIIa with high specificity through competitive and allosteric modes of action.Impaired Akt Phosphorylation in Monocytes of Patients with Rheumatoid Arthritis.Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients.CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens
P2860
Q26774681-CA9DE51E-D142-495B-995E-726CA84DD430Q28554987-89F09069-9B54-4B75-BA3A-078BD4EFC409Q33886544-C41E27C7-CFE3-4778-BB68-DFBE698273C4Q34003845-944922BB-FEA9-410B-AFCE-F51DB2E006BCQ34472557-35BC90BC-B629-4F96-9453-15C924D3C6C3Q35648024-3BD43FAF-F7A0-4A0D-B9E6-EBD11AB6EB44Q36008257-663B98D9-E385-42ED-9BC3-AC799EC19252Q36477414-DF0305E1-D6A4-415B-8665-CC8C31359AEFQ36825365-5CDAAC0F-1823-4DF8-9E5F-4EE29B5B689BQ36935158-640B4572-F670-4681-895B-37A37AF69D51Q37695329-AC979E3C-F7E6-48C8-BA9B-3DC39C229288Q38204490-CAC862C0-07B6-403D-8A46-8E9D850F755CQ38207732-44CE4FA4-495B-4CA5-9511-3AA56E7DD7F1Q38411099-41D3D94B-E818-42FA-B18A-2B18E2518726Q38991972-4247F1BB-74F8-4EEE-A631-5AF165C912CAQ43143550-9C31E688-576A-45EA-87E5-C61C2DF98F7AQ44870772-E584371F-FFAB-438C-A1BD-6B4D3D9F94FFQ47287433-98F2C9DF-E697-4E20-B39E-CFD2F350DCABQ51250802-DDE8E947-A0F8-4CA2-AA0A-FAF7F1277D1FQ52842630-209D0AA1-A482-402A-A77C-A1B6A594178BQ57132096-8F134F8A-1F95-477B-99C3-E72E81F696CE
P2860
FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@ast
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@en
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@en-gb
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@nl
type
label
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@ast
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@en
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@en-gb
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@nl
prefLabel
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@ast
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@en
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@en-gb
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@nl
P2093
P2860
P50
P1433
P1476
FcγRIIIa expression on monocyt ...... ponse to methotrexate therapy.
@en
P2093
Ann W Morgan
Christopher J Charles
Dawn L Cooper
Jackie Nam
James I Robinson
Sarah L Mackie
Stephen G Martin
YEAR Consortium
P2860
P304
P356
10.1371/JOURNAL.PONE.0028918
P407
P577
2012-01-03T00:00:00Z
P5875
P6179
1030853293